Foresite Capital Fund V, L.P.
CIK 1792204 · last filed 2026-01-12
Foresite Capital Fund V, L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing shows the insider bought $63.0M of ALMS on Jan 12, 2026. Across all open-market trades the lifetime net is +$435.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $28.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.41M
2
5
$435.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALMS | 10%+ Owner | 1,176,470 | $24.15 | $28.41M | $423.00M | 2 | 2026-01-12 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | 10%+ Owner | 3,585,346 | $4.06 | $14.56M | $12.50M | 1 | 2023-01-03 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | ALMS | Buy (P) | +3,705,876 | $63.00M | EDGAR |
| 2024-07-03 | ALMS | Mixed | +125,788,356 | $360.00M | EDGAR |
| 2023-01-03 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Buy (P) | +2,500,000 | $12.50M | EDGAR |
| 2021-12-23 | — | Buy (P) | +1,625,000 | $16.25M | |
| 2021-02-23 | — | Buy (P) | +2,410,000 | $24.10M |